Campbell Samuel G, Magee Kirk D, Zed Peter J, Froese Patrick, Etsell Glenn, LaPierre Alan, Warren Donna, MacKinley Robert R, Butler Michael B, Kovacs George, Petrie David A
Department of Emergency Medicine and Anesthesia, Dalhousie University, Halifax, Nova Scotia, Canada.
Faculty of Pharmaceutical Sciences and Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
World J Emerg Med. 2016;7(1):13-8. doi: 10.5847/wjem.j.1920-8642.2016.01.002.
This prospective, randomized trial was undertaken to evaluate the utility of adding end-tidal capnometry (ETC) to pulse oximetry (PO) in patients undergoing procedural sedation and analgesia (PSA) in the emergency department (ED).
The patients were randomized to monitoring with or without ETC in addition to the current standard of care. Primary endpoints included respiratory adverse events, with secondary endpoints of level of sedation, hypotension, other PSA-related adverse events and patient satisfaction.
Of 986 patients, 501 were randomized to usual care and 485 to additional ETC monitoring. In this series, 48% of the patients were female, with a mean age of 46 years. Orthopedic manipulations (71%), cardioversion (12%) and abscess incision and drainage (12%) were the most common procedures, and propofol and fentanyl were the sedative/analgesic combination used for most patients. There was no difference in patients experiencing de-saturation (SaO2<90%) between the two groups; however, patients in the ETC group were more likely to require airway repositioning (12.9% vs. 9.3%, P=0.003). Hypotension (SBP<100 mmHg or <85 mmHg if baseline <100 mmHg) was observed in 16 (3.3%) patients in the ETC group and 7 (1.4%) in the control group (P=0.048).
The addition of ETC does not appear to change any clinically significant outcomes. We found an increased incidence of the use of airway repositioning maneuvers and hypotension in cases where ETC was used. We do not believe that ETC should be recommended as a standard of care for the monitoring of patients undergoing PSA.
本前瞻性随机试验旨在评估在急诊科对接受程序性镇静镇痛(PSA)的患者,在脉搏血氧饱和度测定(PO)基础上增加呼气末二氧化碳监测(ETC)的效用。
患者被随机分为除当前标准治疗外,接受或不接受ETC监测。主要终点包括呼吸不良事件,次要终点为镇静水平、低血压、其他与PSA相关的不良事件及患者满意度。
986例患者中,501例被随机分配至常规治疗组,485例被分配至额外ETC监测组。在该系列中,48%的患者为女性,平均年龄46岁。骨科手法操作(71%)、心脏复律(12%)及脓肿切开引流(12%)是最常见的操作,丙泊酚和芬太尼是大多数患者使用的镇静/镇痛组合。两组间出现氧饱和度降低(SaO2<90%)的患者无差异;然而,ETC组患者更有可能需要重新调整气道位置(12.9%对9.3%,P=0.003)。ETC组16例(3.3%)患者及对照组7例(1.4%)患者出现低血压(收缩压<100 mmHg,若基线<100 mmHg则为<85 mmHg)(P=0.048)。
增加ETC似乎并未改变任何具有临床意义的结果。我们发现在使用ETC的情况下,气道重新定位操作和低血压的发生率有所增加。我们认为不应推荐将ETC作为监测接受PSA患者的标准治疗手段。